DAFTAR PUSTAKA. 32. Andersen et al, Use of a Symptom Index, CA125, and HE4 to predict ovarian

Transcription

1 DAFTAR PUSTAKA 32. Andersen et al, Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer, Elsevier Journal, Gynecology Oncology 116 (2010) Allard W. J. and Moore R. G, HE4 And CA 125 Combined For The Improved Management Ovarian Cancer, Department of Obstetrics and Gynecology Women and Infants Hospital Alpert Medical School Brown University, P.Boyleand, B.Levin, International Agency for Research on Cancer, and World Health Organization, World cancer report 2008, Distributed by WHO Press, Geneva, Switzerland, Iqbal TR, Evaluasi Penatalaksanaan Kanker Ovarium Epitel di RSUP H. Adam Malik Medan Januari Desember Departemen Obstetri dan Ginekologi Fakultas Kedokteran, Sihombing M, Sirait AM, Angka Ketahanan Hidup Penderita Kanker Ovarium di RS. Dr. Cipto Mangunkusumo Jakarta, Puslitbang dan Biomedis Farmasi Balitbangkes RI, Jakarta, Majalah Kedokteran Indonesia vol.57 No.10, Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97(10): Daniel L. Clarke-Pearson, Clinical Practice, Screening for Ovarian Cancer, New England Journal of Medicine, 2009;361:170.

2 39. Goff, L. Mandel, H. G. Muntz, and C. H. Melancon, Ovarian carcinoma diagnosis: results of a national ovarian cancer survey, Cancer, vol. 89, no. 10, pp , Kenemans P et al: CA 125 in gynecological pathology-a review. European Journal of Obstetrics & Gynecology and Reproductive Biology 1993;49: Jemal, R. Siegel, E. Ward, et al., Cancer statistics, 2008, CA: A Cancer Journal for Clinicians, vol. 58, no. 2, pp , I. Hellstrom, J. Raycraft, M. Hayden-Ledbetter, et al., The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma, Cancer Research, vol. 63, no. 13, pp , Jinping Li, Sean Dowdy et al : HE4 as a Biomarker for Ovarian and Endometrial Cancer Management. Expert Rev Mol Diagn. 2009;9(6): R. G. Moore, A. K. Brown, M. C. Miller, et al., The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass, Gynecologic Oncology, vol. 108, no. 2, pp , HE4 Enzyme Imunometric Assay, Fujirebio Diagnostic Inc. Goteborg. Sweden

3 46. Busmar B, Kanker Ovarium, Onkologi Ginekologi Edisi pertama, Bina Pustaka Sarwono Prawirohardjo, Jakarta, P C. R. Bankhead, C. Collins, H. Stokes-Lampard, et al., Identifying symptoms of ovarian cancer: a qualitative and quantitative study, BJOG, vol. 115, no. 8, pp , R. Twombly, Cancer killer maybe silent nomore, Journal of the National Cancer Institute, vol. 99, no. 18, pp , T. H. Bourne, S. Campbell, K.M. Reynolds, et al., Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging, British Medical Journal, vol. 306, no. 6884, pp , R. Drapkin, H. H. von Horsten, Y. Lin, et al., Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas, Cancer Research, vol. 65, no. 6, pp , J.R.van Nagell Jr, P.D.DePriest, M.B.Reedy,etal., The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer, Gynecologic Oncology, vol. 77, no. 3, pp , S. Sato, Y. Yokoyama, T. Sakamoto, M. Futagami, and Y. Saito, Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography, Cancer, vol. 89, no. 3,p , 2000.

4 53. Sadler TW. Urogenital system. Sadler TW (ed). Langman s Medical Embryology. Ninth Edition. 2000; p Speroff L, Fritz MA. The Uterus. Speroff L, Fritz MA (eds). Clinical Gynecologic Endocrinology and Infertility. eighth edition. Lippincott Williams Wilkins, New York, Auersperg N, Maines-Bandiera SL, Dyck HG. Ovarian carcinogenesis and the biology of ovarian surface epithelium. J Cell Physiol 1997; 173: Cannistra SA, Gershenson DM, Recht A. Ovarian cancer, peritoneal carcinoma and fallopian tube carcinoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008: Yaznil MR, Khoman JS. Apakah Kanker Ovarium Epitel Berasal Dari Ovarium?. Minireferat Onkogin. Divisi Onkologi Ginekologi Departemen Obstetri Ginekologi FK USU, Bingle L, et al. The Putative Ovarian Tumor Marker Gene HE4 (WFDC2), Is Expressed In Normal Tissue And Undergoes Complex Alternative Splicing To Yield Multiple Protein Isoforms, Nature Publishing Group, Oncogene, K. Huhtinen, P. Suvitie, J. Hiissa, et al., Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts, British Journal of Cancer, vol.100, no. 8, pp , 2009

5 60. Berek JS, Ovarian and Fallopian Tube Cancer, Berek and Novak s Gynecology 14th edition, Lippincott Williams and Wilkins, 2007, p R. G. Moore, D. S. McMeekin, A. K. Brown, et al., A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass, Gynecologic Oncology, vol. 112, no. 1, pp , L.H.Smith, C.R.Morris, S.Yasmeen, A.Parikh-Patel, R.D.Cress, and P. S. Romano, Ovarian cancer: can we make the clinical diagnosis earlier? Cancer, vol. 104, no. 7, pp , 2005.